Data from EPG Health Media - Curated by Toby Galbraith - Last updated 16 November 2018

Browse related ATC

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
OTHER ANTINEOPLASTIC AGENTS
Monoclonal antibodies
edrecolomab
rituximab
trastuzumab
gemtuzumab
cetuximab
bevacizumab
panitumumab
catumaxomab
ofatumumab
ipilimumab
brentuximab vedotin
pertuzumab
trastuzumab emtansine
obinutuzumab
dinutuximab

Drug

Trazimera▼ (Trastuzumab)

ATC
Orphan drug
No

Updated 7 hours ago

Kanjinti▼ (Trastuzumab)

ATC
Orphan drug
No

Updated 2 months ago

Herzuma▼ (Trastuzumab)

ATC
Orphan drug
No

Updated 5 months ago

Mylotarg▼ (Gemtuzumab ozogamicin)

ATC
Orphan drug
Yes

Updated 3 months ago

Mvasi▼ (Bevacizumab)

ATC
Orphan drug
No

Updated 8 months ago

Ontruzant (Trastuzumab)

ATC
Orphan drug
No

Updated 9 months ago

Rituzena (Rituximab)

ATC
Orphan drug
No

Updated 3 months ago

Blitzima▼ (Rituximab)

ATC
Orphan drug
No

Updated 3 months ago

Ritemvia (Rituximab)

ATC
Orphan drug
No

Updated 3 months ago

Rixathon▼ (Rituximab)

ATC
Orphan drug
No

Updated 3 months ago